Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04502563 · ClinicalTrials.gov registry record · NA
LINK-HF2 - Remote Monitoring Analytics in Heart Failure
A NA study of Heart Failure, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 4
- Study locations
NCT04502563: Completed NA study of Heart Failure, sponsored by VA Office of Research and Development.
NCT04502563 is a NA study of Heart Failure that has completed, run by VA Office of Research and Development. The registered enrollment target is 208 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04502563, a NA study of Heart Failure, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 4
- Study locations
Study Summary
Heart failure (HF) is a type of heart disease that leads to need of admissions to the hospital during worsening of symptoms. These admissions are expensive and very inconvenient for patients. The investigators have previously shown that monitoring of patients with a using a small wearable sensor combined with a mathematical model can detect worsening of HF before the patient needs medical care. In this study the investigators will test whether the remote monitoring and prediction of HF worsening can be used to find out when patients are at risk, change their treatment and avoid a hospitalization. The study will enroll 240 Veterans with HF and randomly assign half of them to monitoring and communication of the information on HF worsening to their medical teams. The investigators hope to find our how to best use this approach in routine care of HF. The investigators also plan to determine if this approach will indeed led to less admissions to the hospital among these patients, shorter hospital stays and better quality of life.
Primary Outcome
90-day hospitalization rate in subjects in active arm vs control arm
Conditions Studied
Interventions
- OTHER Sham comparator
- OTHER Remote monitoring and predictive analytics
Study Locations (4)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Florida
- North Florida/South Georgia Veterans Health System, Gainesville, FL - Gainesville
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Virginia
- Hunter Holmes McGuire VA Medical Center, Richmond, VA - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2024-10-30 |
| Phase | NA |
What the finished NCT04502563 record still lists
NCT04502563 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Sham comparator is the first listed.
NCT04502563 reports a single indexed study location in California, Florida, Utah.
Frequently Asked Questions
What is clinical trial NCT04502563 about?
NCT04502563 is a clinical study titled "LINK-HF2 - Remote Monitoring Analytics in Heart Failure". Heart failure (HF) is a type of heart disease that leads to need of admissions to the hospital during worsening of symptoms. These admissions are expensive and very inconvenient for patients. The investigators have previously shown that monitoring of patients with a using a small wearable sensor com...
What is the current status of trial NCT04502563?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2021-04-19. Estimated completion is 2024-10-30.
What conditions does trial NCT04502563 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04502563?
The interventions under investigation include: Sham comparator (OTHER), Remote monitoring and predictive analytics (OTHER).
Who is sponsoring clinical trial NCT04502563?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04502563 being conducted?
This trial has 4 study locations across California, Florida, Utah, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04502563's enrollment target sits among peer trials
208 161st of 397 higher than 236 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI